Lovotibeglogene autotemcel (Bluebird Bio Inc.) is an investigational gene therapy delivered by autologous hematopoietic stem cell transplantation for the treatment of sickle cell disease.
Lovotibeglogene autotemcel (Bluebird Bio Inc.) is an investigational gene therapy delivered by autologous hematopoietic stem cell transplantation for the treatment of sickle cell disease.